NEW YORK (360Dx) – Softness in the broader markets dragged down the stocks of most diagnostic companies in October, as the 360Dx Index fell almost 9 percent month over month.

The share prices of just five of the 28 companies in the index improved in value last month, paced by Veracyte (+56 percent), followed by Guardant Health (+ 21 percent), which was added to the 360Dx Index this month, and NeoGenomics (+20 percent).

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.